|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: Karen J. Maschke , Michael K. GusmanoPublisher: Bloomsbury Publishing Plc Imprint: Praeger Publishers Inc Weight: 0.680kg ISBN: 9781440861895ISBN 10: 1440861897 Pages: 232 Publication Date: 14 September 2018 Recommended Age: From 7 to 17 years Audience: College/higher education , Professional and scholarly , Tertiary & Higher Education , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of ContentsAcknowledgments Chapter 1 Evidence, Politics, and Medical Care Technology Chapter 2 Evolving Public- and Private-Payer Approaches to Evidence and Health Technology Assessment Chapter 3 Mammography Screening: Vested Interests and Polarization Chapter 4 When Medicare Said No for Amyloid PET Imaging Chapter 5 Placing a Value on Cure: Lessons from the New Generation of Hepatitis C Drugs Chapter 6 Avastin and the Politics of Accelerated Approval Chapter 7 The Path to the Clinic for Stem Cell and Other Regenerative Medicine Interventions Chapter 8 Conclusion: The 21st Century Cures Act and the Future of Health Technology Assessment Notes Bibliography IndexReviewsAuthor InformationKaren J. Maschke is research scholar at the Hastings Center with expertise on the ethical, legal, and policy issues associated with new biomedical technologies. She is editor of IRB: Ethics & Human Research. Michael K. Gusmano is associate professor of health policy at Rutgers University and research scholar at the Hastings Center with expertise on the politics of health reform, comparative politics, and health technology assessment. Tab Content 6Author Website:Countries AvailableAll regions |